Pulmonx Corp. (LUNG) NASDAQ

$9.26 0.15 (1.65%)

Market Cap: $351.08M

As of 03/28/24 02:24 PM EDT. Market open.

(LUNG)

Pulmonx Corp. (LUNG)
NASDAQ

$9.26
0.15 (1.65%)

Market Cap: $351.08M

As of 03/28/24 02:24 PM EDT. Market open.

Add to Portfolio

pulmonx is focused on developing life-changing technologies that improve the lives of patients suffering from lung disease. the company’s first commercial products address emphysema, a form of copd (chronic obstructive pulmonary disease) and the largest unmet medical need in pulmonology. with emphysema, breathing becomes increasingly more difficult as the disease progresses. today in the u.s., ... read more

pulmonx is focused on developing life-changing technologies that improve the lives of patients suffering from lung disease. the company’s first commercial products address emphysema, a form of copd (chronic obstructive pulmonary disease) and the largest unmet medical need in pulmonology. with emphysema, breathing becomes increasingly more difficult as the disease progresses. today in the u.s., advanced emphysema patients have no available alternatives but lung volume reduction surgery, which is associated with high morbidity and mortality, and lung transplantation, which is limited by the availability of donor organs. pulmonx has developed the zephyr endobronchial valve (ebv) therapy, a non-surgical, investigational approach to treating emphysema. the minimally invasive zephyr valve is a tiny, one-way valve designed to reduce the volume of the diseased regions of the lung by blocking airflow, in order to improve breathing and increase activity levels. no surgery is involved in the simp read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
URL
Address
700 Chesapeake Dr, California, Redwood City, 94063.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
236
URL
Address
700 Chesapeake Dr, California, Redwood City, 94063.
PRICE CHART FOR PULMONX CORP
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.12
Previous Close
$9.11
Days Range
$9.03 - $9.17
52 week range
$7.75 - $14.84
Volume
312,590
Avg. Volume (30 days)
649,891
Market Cap
$351.08M
Dividend Yield
-
P/E
(5.77)
Shares Outstanding
38,537,356
Open
$9.12
Previous Close
$9.11
Days Range
$9.03 - $9.17
52 week range
$7.75 - $14.84
Volume
312,590
Avg. Volume (30 days)
649,891
Market Cap
$351.08M
Dividend Yield
-
P/E
(5.77)
Shares Outstanding
38,537,356
FINANCIAL STATEMENTS FOR PULMONX CORP
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PULMONX CORP
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Rose Geoffrey BeranCHIEF COMMERCIAL OFFICERMar 22, 2024 Sale$9.361,18411,082307,868Mar 26, 2024, 05:53 PM
Rose Geoffrey BeranCHIEF COMMERCIAL OFFICERMar 01, 2024 Sale$9.063,09728,059242,621Mar 05, 2024, 06:22 PM
McKune JohnINTERIM CFOMar 01, 2024 Sale$9.061,0789,76748,333Mar 05, 2024, 06:20 PM
French Glendon E. IIIPRESIDENT AND CEOMar 01, 2024 Sale$9.066,95463,0031,122,523Mar 05, 2024, 06:15 PM
Rose Geoffrey BeranCHIEF COMMERCIAL OFFICERFeb 22, 2024 Sale$14.201,18416,813243,049Feb 26, 2024, 06:23 PM
French Glendon E. IIIPRESIDENT AND CEOFeb 15, 2024 Sale$14.6020,000292,0001,121,344Feb 16, 2024, 07:11 PM
Rose Geoffrey BeranCHIEF COMMERCIAL OFFICERJan 22, 2024 Sale$13.131,18415,546244,233Jan 24, 2024, 05:41 PM
French Glendon E. IIIPRESIDENT AND CEOJan 18, 2024 Sale$12.7710,000127,7001,141,344Jan 22, 2024, 06:05 PM
Rose Geoffrey BeranChief Commercial OfficerDec 22, 2023 Sale$12.751,18415,096245,417Dec 27, 2023, 04:19 PM
French Glendon E. IIIPresident and CEODec 21, 2023 Sale$12.4210,000124,2001,151,344Dec 22, 2023, 06:12 PM
Rose Geoffrey BeranChief Commercial OfficerDec 01, 2023 Sale$10.342,86829,655249,073Dec 05, 2023, 05:46 PM
McKune JohnInterim CFODec 01, 2023 Sale$10.349429,73941,221Dec 05, 2023, 05:44 PM
Lehman David AaronGeneral CounselDec 01, 2023 Sale$10.343,80939,381153,246Dec 05, 2023, 05:42 PM
French Glendon E. IIIPresident and CEODec 01, 2023 Sale$10.346,67669,0301,166,980Dec 05, 2023, 05:41 PM
Rose Geoffrey BeranChief Commercial OfficerNov 22, 2023 Sale$10.601,18412,550249,469Nov 27, 2023, 06:14 PM
Rose Geoffrey BeranChief Commercial OfficerOct 23, 2023 Sale$8.351,1849,886250,653Oct 25, 2023, 06:20 PM
Rose Geoffrey BeranChief Commercial OfficerSep 22, 2023 Sale$10.511,18412,444251,837Sep 26, 2023, 06:15 PM
Sung DerrickChief Financial OfficerSep 01, 2023 Sale$10.004,21942,201394,862Sep 06, 2023, 06:07 PM
Rose Geoffrey BeranChief Commercial OfficerSep 01, 2023 Sale$10.012,84328,458255,471Sep 06, 2023, 06:03 PM
Lehman David AaronGeneral CounselSep 01, 2023 Sale$10.013,77237,758157,022Sep 06, 2023, 05:52 PM
French Glendon E. IIIPresident and CEOSep 01, 2023 Sale$10.016,52765,3351,173,516Sep 06, 2023, 05:50 PM
Rose Geoffrey BeranChief Commercial OfficerAug 23, 2023 Sale$10.541,18412,479255,864Aug 25, 2023, 05:40 PM
French Glendon E. IIIPresident and CEOJul 20, 2023 Sale$12.6815,000190,2001,174,547Jul 24, 2023, 06:30 PM
French Glendon E. IIIPresident and CEOJun 15, 2023 Sale$12.6810,000126,8001,189,547Jun 20, 2023, 06:08 PM
Sung DerrickChief Financial OfficerJun 01, 2023 Sale$11.494,22248,507399,083Jun 02, 2023, 06:51 PM
Rose Geoffrey BeranChief Commercial OfficerJun 01, 2023 Sale$11.482,84532,661259,500Jun 02, 2023, 06:47 PM
Lehman David AaronGeneral CounselJun 01, 2023 Sale$11.483,77643,348160,797Jun 02, 2023, 06:40 PM
French Glendon E. IIIPresident and CEOJun 01, 2023 Sale$11.486,53375,0091,205,048Jun 02, 2023, 06:38 PM
Sung DerrickChief Financial OfficerMar 01, 2023 Sale$11.031,26413,942262,288Mar 03, 2023, 07:09 PM
Rose Geoffrey BeranChief Commercial OfficerMar 01, 2023 Sale$11.031,20613,302181,762Mar 03, 2023, 07:02 PM
Lehman David AaronGeneral CounselMar 01, 2023 Sale$11.031,26413,94243,702Mar 03, 2023, 07:00 PM
French Glendon E. IIIPresident and CEOMar 01, 2023 Sale$11.032,89531,9321,034,291Mar 03, 2023, 06:58 PM
French Glendon E. IIIPresident and CEODec 01, 2022 Sale$5.933,63121,5321,036,508Dec 05, 2022, 07:01 PM
Lehman David AaronGeneral CounselDec 01, 2022 Sale$5.931,0696,33944,842Dec 05, 2022, 07:00 PM
Rose Geoffrey BeranChief Commercial OfficerDec 01, 2022 Sale$5.931,0556,256181,710Dec 05, 2022, 06:58 PM
Sung DerrickChief Financial OfficerDec 01, 2022 Sale$5.931,0696,339263,428Dec 05, 2022, 06:35 PM
Lynch Alissa HsuDirectorNov 29, 2022 Buy$5.511,7009,36711,910Dec 01, 2022, 05:33 PM
Sung DerrickChief Financial OfficerNov 14, 2022 Option Exercise$2.2010,00022,000263,815Nov 14, 2022, 08:06 PM
French Glendon E. IIIPresident and CEONov 14, 2022 Option Exercise$2.2010,00022,0001,037,944Nov 14, 2022, 08:04 PM
Ferrari RichardDirectorNov 08, 2022 Buy$5.315,43828,87430,035Nov 10, 2022, 06:02 PM
French Glendon E. IIIPresident and CEOSep 15, 2022 Sale$20.0025,000500,0001,027,944Sep 19, 2022, 05:23 PM
Sung DerrickChief Financial OfficerSep 01, 2022 Sale$17.871,08219,335254,505Sep 06, 2022, 04:53 PM
Rose Geoffrey BeranChief Commercial OfficerSep 01, 2022 Sale$17.891,02718,372182,747Sep 06, 2022, 04:52 PM
Lehman David AaronGeneral CounselSep 01, 2022 Sale$17.881,08219,35045,919Sep 06, 2022, 04:51 PM
French Glendon E. IIIPresident and CEOSep 01, 2022 Sale$17.872,94052,5381,054,870Sep 06, 2022, 04:50 PM
French Glendon E. IIIPresident and CEOAug 18, 2022 Sale$20.5950,0001,029,5001,055,884Aug 22, 2022, 05:45 PM
Rose Geoffrey BeranChief Commercial OfficerJun 01, 2022 Sale$18.051,01118,249183,763Jun 03, 2022, 06:12 PM
Sung DerrickChief Financial OfficerJun 01, 2022 Sale$18.051,06519,223255,576Jun 03, 2022, 06:07 PM
French Glendon E. IIIPresident and CEOJun 01, 2022 Sale$18.052,52345,5401,106,519Jun 03, 2022, 06:02 PM
Lehman David AaronGeneral CounselJun 01, 2022 Sale$18.051,06519,22346,990Jun 03, 2022, 05:57 PM
Rose Geoffrey BeranChief Commercial OfficerMar 10, 2022 Option Exercise$2.1029,42761,797184,129Mar 11, 2022, 06:06 PM
Sung DerrickChief Financial OfficerMar 01, 2022 Sale$25.9145811,867224,962Mar 03, 2022, 06:14 PM
Rose Geoffrey BeranChief Commercial OfficerMar 01, 2022 Sale$25.9142611,038123,702Mar 03, 2022, 06:13 PM
Lehman David AaronGeneral CounselMar 01, 2022 Sale$25.9145811,86716,376Mar 03, 2022, 06:11 PM
French Glendon E. IIIPresident and CEOMar 01, 2022 Sale$25.911,13229,3301,062,817Mar 03, 2022, 06:03 PM
French Glendon E. IIIPresident and CEOFeb 18, 2022 Sale$26.9112,500336,3851,067,888Feb 22, 2022, 05:45 PM
French Glendon E. IIIPresident and CEOFeb 17, 2022 Sale$27.2212,500340,2501,076,449Feb 22, 2022, 05:45 PM
French Glendon E. IIIPresident and CEOJan 21, 2022 Sale$24.2412,500302,9451,089,336Jan 24, 2022, 05:41 PM
French Glendon E. IIIPresident and CEOJan 20, 2022 Sale$25.9812,500324,7501,101,449Jan 24, 2022, 05:41 PM
French Glendon E. IIIPresident and CEODec 16, 2021 Sale$31.0525,000776,2201,120,547Dec 17, 2021, 08:06 PM
Rose Geoffrey BeranChief Commercial OfficerDec 15, 2021 Sale$30.5522,000672,002123,819Dec 16, 2021, 06:22 PM
Sung DerrickChief Financial OfficerDec 15, 2021 Sale$30.533,00091,585225,444Dec 16, 2021, 05:48 PM
Sung DerrickChief Financial OfficerDec 14, 2021 Sale$32.893,00098,670228,420Dec 16, 2021, 05:48 PM
French Glendon E. IIIPresident and CEODec 01, 2021 Sale$32.731,42146,5091,138,949Dec 03, 2021, 07:11 PM
French Glendon E. IIIPresident and CEOMay 20, 2021 Option Exercise$2.2010,00022,0001,259,884Dec 03, 2021, 07:08 PM
French Glendon E. IIIPresident and CEOMay 20, 2021 Sale$41.9525,0001,048,7801,254,825Dec 03, 2021, 07:08 PM
French Glendon E. IIIPresident and CEOApr 15, 2021 Option Exercise$2.2025,00055,0001,274,884Dec 03, 2021, 06:46 PM
French Glendon E. IIIPresident and CEOApr 15, 2021 Sale$43.7525,0001,093,8561,254,895Dec 03, 2021, 06:46 PM
Lehman David AaronGeneral CounselDec 01, 2021 Sale$32.7338312,53616,834Dec 03, 2021, 06:41 PM
Rose Geoffrey BeranChief Commercial OfficerDec 01, 2021 Sale$32.7335511,619145,459Dec 03, 2021, 06:39 PM
Sung DerrickChief Financial OfficerDec 01, 2021 Sale$32.7338312,536231,420Dec 03, 2021, 06:34 PM
French Glendon E. IIIPresident and CEONov 18, 2021 Sale$35.9825,000899,4711,118,779Nov 22, 2021, 06:44 PM
Rose Geoffrey BeranChief Commercial OfficerNov 15, 2021 Sale$39.947,000279,580145,814Nov 16, 2021, 06:09 PM
French Glendon E. IIIPresident and CEOOct 21, 2021 Sale$39.7525,000993,6811,138,967Oct 22, 2021, 07:11 PM
Rose Geoffrey BeranChief Commercial OfficerOct 15, 2021 Sale$39.447,000276,080152,814Oct 18, 2021, 08:09 PM
Sung DerrickChief Financial OfficerSep 21, 2021 Sale$37.503,000112,500231,803Sep 21, 2021, 08:11 PM
Sung DerrickChief Financial OfficerSep 20, 2021 Sale$37.353,000112,062234,918Sep 21, 2021, 08:11 PM
French Glendon E. IIIPresident and CEOSep 20, 2021 Sale$37.3623,571880,6241,700Sep 20, 2021, 08:45 PM
French Glendon E. IIIPresident and CEOSep 16, 2021 Sale$38.8625,000971,5001,155,370Sep 20, 2021, 08:45 PM
Rose Geoffrey BeranChief Commercial OfficerSep 15, 2021 Sale$38.127,000266,840159,814Sep 17, 2021, 06:42 PM
Sung DerrickChief Financial OfficerSep 01, 2021 Sale$40.0938315,354237,803Sep 03, 2021, 05:58 PM
Rose Geoffrey BeranChief Commercial OfficerSep 01, 2021 Sale$40.0935514,232166,814Sep 03, 2021, 05:55 PM
Lehman David AaronGeneral CounselSep 01, 2021 Sale$40.0938315,35417,217Sep 03, 2021, 05:53 PM
French Glendon E. IIIPresident and CEOSep 01, 2021 Sale$40.091,42156,9681,180,370Sep 03, 2021, 05:50 PM
French Glendon E. IIIPresident and CEOAug 19, 2021 Sale$36.6325,000915,7501,181,791Aug 23, 2021, 06:31 PM
French Glendon E. IIIPresident and CEOAug 19, 2021 Sale$36.591,00036,59023,571Aug 23, 2021, 06:31 PM
Rose Geoffrey BeranChief Commercial OfficerAug 16, 2021 Sale$36.717,000256,970166,885Aug 18, 2021, 08:09 PM
Rose Geoffrey BeranChief Commercial OfficerJul 15, 2021 Sale$38.737,000271,080180,127Jul 19, 2021, 07:49 PM
French Glendon E. IIIPresident and CEOJul 15, 2021 Option Exercise$2.204,3759,6251,231,734Jul 19, 2021, 07:48 PM
French Glendon E. IIIPresident and CEOJul 15, 2021 Sale$38.701,00038,70325,478Jul 19, 2021, 07:48 PM
French Glendon E. IIIPresident and CEOJul 15, 2021 Sale$38.7325,000968,2041,230,397Jul 19, 2021, 07:48 PM
BOSTON SCIENTIFIC CORP10% OwnerJul 13, 2021 Sale$37.452,500,00093,625,0021,488,106Jul 14, 2021, 04:10 PM
Florin Daniel PDirectorJul 12, 2021 Buy$40.002,500100,0007,532Jul 13, 2021, 07:21 PM
Florin Daniel PDirectorJun 25, 2021 Buy$44.122,22298,0355,032Jun 28, 2021, 05:33 PM
French Glendon E. IIIPresident and CEOJun 17, 2021 Option Exercise$2.204,3759,6251,252,359Jun 21, 2021, 06:26 PM
French Glendon E. IIIPresident and CEOJun 17, 2021 Sale$42.681,00042,68025,571Jun 21, 2021, 06:26 PM
French Glendon E. IIIPresident and CEOJun 17, 2021 Sale$42.9625,0001,073,9051,232,288Jun 21, 2021, 06:26 PM
Rose Geoffrey BeranChief Commercial OfficerMay 24, 2021 Sale$40.884,797196,085163,719May 25, 2021, 05:18 PM
Rose Geoffrey BeranChief Commercial OfficerApr 19, 2021 Sale$43.244,797207,422121,470Apr 21, 2021, 05:26 PM
French Glendon E. IIIPresident and CEOApr 15, 2021 Sale$43.701,00043,70027,571Apr 16, 2021, 05:03 PM
French Glendon E. IIIPresident and CEOApr 15, 2021 Sale$43.7525,0001,093,8561,229,895Apr 16, 2021, 05:03 PM
BOSTON SCIENTIFIC CORP10% OwnerApr 06, 2021 Sale$43.60650,00028,339,9993,988,106Apr 08, 2021, 04:20 PM
Rose Geoffrey BeranChief Commercial OfficerApr 05, 2021 Sale$47.654,797228,557104,586Apr 07, 2021, 09:05 PM
Rose Geoffrey BeranChief Commercial OfficerApr 05, 2021 Sale$47.644,797228,521109,330Apr 06, 2021, 07:41 PM
Sung DerrickChief Financial OfficerApr 05, 2021 Sale$47.605,000238,020223,879Apr 06, 2021, 07:40 PM
Sung DerrickChief Financial OfficerApr 06, 2021 Sale$47.125,000235,602220,834Apr 06, 2021, 07:40 PM
BOSTON SCIENTIFIC CORP10% OwnerMar 30, 2021 Sale$40.801,350,00055,079,9994,638,106Apr 01, 2021, 04:24 PM
Florin Daniel PDirectorOct 05, 2020 Buy$19.0015,789299,99115,789Oct 05, 2020, 04:17 PM
FERRARI RICHARD MDirectorOct 05, 2020 Buy$19.0013,157249,98316,187Oct 05, 2020, 04:16 PM
Melenikiotou GeorgiaDirectorOct 05, 2020 Buy$19.0026,315499,98526,315Oct 05, 2020, 04:16 PM
Mead Dana G Jr.DirectorOct 05, 2020 Buy$19.0026,315499,98526,315Oct 05, 2020, 04:16 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER03/22/202411,082
Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER03/01/202428,059
McKune JohnINTERIM CFO03/01/20249,767
French Glendon E. IIIPRESIDENT AND CEO03/01/202463,003
Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER02/22/202416,813
French Glendon E. IIIPRESIDENT AND CEO02/15/2024292,000
Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER01/22/202415,546
French Glendon E. IIIPRESIDENT AND CEO01/18/2024127,700
Rose Geoffrey BeranChief Commercial Officer12/22/202315,096
French Glendon E. IIIPresident and CEO12/21/2023124,200
Rose Geoffrey BeranChief Commercial Officer12/01/202329,655
McKune JohnInterim CFO12/01/20239,739
Lehman David AaronGeneral Counsel12/01/202339,381
French Glendon E. IIIPresident and CEO12/01/202369,030
Rose Geoffrey BeranChief Commercial Officer11/22/202312,550
Rose Geoffrey BeranChief Commercial Officer10/23/20239,886
Rose Geoffrey BeranChief Commercial Officer09/22/202312,444
Sung DerrickChief Financial Officer09/01/202342,201
Rose Geoffrey BeranChief Commercial Officer09/01/202328,458
Lehman David AaronGeneral Counsel09/01/202337,758
French Glendon E. IIIPresident and CEO09/01/202365,335
Rose Geoffrey BeranChief Commercial Officer08/23/202312,479
French Glendon E. IIIPresident and CEO07/20/2023190,200
French Glendon E. IIIPresident and CEO06/15/2023126,800
Sung DerrickChief Financial Officer06/01/202348,507
Rose Geoffrey BeranChief Commercial Officer06/01/202332,661
Lehman David AaronGeneral Counsel06/01/202343,348
French Glendon E. IIIPresident and CEO06/01/202375,009
Sung DerrickChief Financial Officer03/01/202313,942
Rose Geoffrey BeranChief Commercial Officer03/01/202313,302
Lehman David AaronGeneral Counsel03/01/202313,942
French Glendon E. IIIPresident and CEO03/01/202331,932
French Glendon E. IIIPresident and CEO12/01/202221,532
Lehman David AaronGeneral Counsel12/01/20226,339
Rose Geoffrey BeranChief Commercial Officer12/01/20226,256
Sung DerrickChief Financial Officer12/01/20226,339
Lynch Alissa HsuDirector11/29/20229,367
Sung DerrickChief Financial Officer11/14/202222,000
French Glendon E. IIIPresident and CEO11/14/202222,000
Ferrari RichardDirector11/08/202228,874
French Glendon E. IIIPresident and CEO09/15/2022500,000
Sung DerrickChief Financial Officer09/01/202219,335
Rose Geoffrey BeranChief Commercial Officer09/01/202218,372
Lehman David AaronGeneral Counsel09/01/202219,350
French Glendon E. IIIPresident and CEO09/01/202252,538
French Glendon E. IIIPresident and CEO08/18/20221,029,500
Rose Geoffrey BeranChief Commercial Officer06/01/202218,249
Sung DerrickChief Financial Officer06/01/202219,223
French Glendon E. IIIPresident and CEO06/01/202245,540
Lehman David AaronGeneral Counsel06/01/202219,223
Rose Geoffrey BeranChief Commercial Officer03/10/202261,797
Sung DerrickChief Financial Officer03/01/202211,867
Rose Geoffrey BeranChief Commercial Officer03/01/202211,038
Lehman David AaronGeneral Counsel03/01/202211,867
French Glendon E. IIIPresident and CEO03/01/202229,330
French Glendon E. IIIPresident and CEO02/18/2022336,385
French Glendon E. IIIPresident and CEO02/17/2022340,250
French Glendon E. IIIPresident and CEO01/21/2022302,945
French Glendon E. IIIPresident and CEO01/20/2022324,750
French Glendon E. IIIPresident and CEO12/16/2021776,220
Rose Geoffrey BeranChief Commercial Officer12/15/2021672,002
Sung DerrickChief Financial Officer12/15/202191,585
Sung DerrickChief Financial Officer12/14/202198,670
French Glendon E. IIIPresident and CEO12/01/202146,509
French Glendon E. IIIPresident and CEO05/20/202122,000
French Glendon E. IIIPresident and CEO05/20/20211,048,780
French Glendon E. IIIPresident and CEO04/15/202155,000
French Glendon E. IIIPresident and CEO04/15/20211,093,856
Lehman David AaronGeneral Counsel12/01/202112,536
Rose Geoffrey BeranChief Commercial Officer12/01/202111,619
Sung DerrickChief Financial Officer12/01/202112,536
French Glendon E. IIIPresident and CEO11/18/2021899,471
Rose Geoffrey BeranChief Commercial Officer11/15/2021279,580
French Glendon E. IIIPresident and CEO10/21/2021993,681
Rose Geoffrey BeranChief Commercial Officer10/15/2021276,080
Sung DerrickChief Financial Officer09/21/2021112,500
Sung DerrickChief Financial Officer09/20/2021112,062
French Glendon E. IIIPresident and CEO09/20/2021880,624
French Glendon E. IIIPresident and CEO09/16/2021971,500
Rose Geoffrey BeranChief Commercial Officer09/15/2021266,840
Sung DerrickChief Financial Officer09/01/202115,354
Rose Geoffrey BeranChief Commercial Officer09/01/202114,232
Lehman David AaronGeneral Counsel09/01/202115,354
French Glendon E. IIIPresident and CEO09/01/202156,968
French Glendon E. IIIPresident and CEO08/19/2021915,750
French Glendon E. IIIPresident and CEO08/19/202136,590
Rose Geoffrey BeranChief Commercial Officer08/16/2021256,970
Rose Geoffrey BeranChief Commercial Officer07/15/2021271,080
French Glendon E. IIIPresident and CEO07/15/20219,625
French Glendon E. IIIPresident and CEO07/15/202138,703
French Glendon E. IIIPresident and CEO07/15/2021968,204
BOSTON SCIENTIFIC CORP10% Owner07/13/202193,625,002
Florin Daniel PDirector07/12/2021100,000
Florin Daniel PDirector06/25/202198,035
French Glendon E. IIIPresident and CEO06/17/20219,625
French Glendon E. IIIPresident and CEO06/17/202142,680
French Glendon E. IIIPresident and CEO06/17/20211,073,905
Rose Geoffrey BeranChief Commercial Officer05/24/2021196,085
Rose Geoffrey BeranChief Commercial Officer04/19/2021207,422
French Glendon E. IIIPresident and CEO04/15/202143,700
French Glendon E. IIIPresident and CEO04/15/20211,093,856
BOSTON SCIENTIFIC CORP10% Owner04/06/202128,339,999
Rose Geoffrey BeranChief Commercial Officer04/05/2021228,557
Rose Geoffrey BeranChief Commercial Officer04/05/2021228,521
Sung DerrickChief Financial Officer04/05/2021238,020
Sung DerrickChief Financial Officer04/06/2021235,602
BOSTON SCIENTIFIC CORP10% Owner03/30/202155,079,999
Florin Daniel PDirector10/05/2020299,991
FERRARI RICHARD MDirector10/05/2020249,983
Melenikiotou GeorgiaDirector10/05/2020499,985
Mead Dana G Jr.Director10/05/2020499,985
Load More Insider Transactions
FUNDS WITH A POSITION IN PULMONX CORP
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,117,0630.00101%6.18%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)1,017,9580.23%ExitedOther
GEODE CAPITAL MANAGEMENT, LLC806,5050.00108%5.51%Other
D. E. SHAW & CO., INC.622,5880.00694%-6.85%Other
RENAISSANCE TECHNOLOGIES LLC195,1630.00385%150.18%Other
HOLOCENE ADVISORS, LP93,1530.00463%No changeGrowth At A Reasonable Price
TUDOR INVESTMENT CORP ET AL52,3470.00537%NewEvent Driven, Other
AQR CAPITAL MANAGEMENT LLC34,6660.00083%NewOther
CHANGE IN SHARES OUTSTANDING FOR PULMONX CORP
STOCK BUYBACKS FOR PULMONX CORP
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.69%
1Q
12/31/2023
06/30/2023
1.49%
2Q
12/31/2023
03/31/2023
2.15%
3Q
12/31/2023
12/31/2022
2.67%
4Q
12/31/2023
09/30/2022
3.20%
5Q
12/31/2023
06/30/2022
3.72%
6Q
12/31/2023
03/31/2022
4.28%
7Q
12/31/2023
12/31/2021
4.75%
8Q
12/31/2023
09/30/2021
5.30%
9Q
12/31/2023
06/30/2021
6.49%
10Q
12/31/2023
03/31/2021
8.51%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.69%
1Q
06/30/2023
1.49%
2Q
03/31/2023
2.15%
3Q
12/31/2022
2.67%
4Q
09/30/2022
3.20%
5Q
06/30/2022
3.72%
6Q
03/31/2022
4.28%
7Q
12/31/2021
4.75%
8Q
09/30/2021
5.30%
9Q
06/30/2021
6.49%
10Q
03/31/2021
8.51%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PULMONX CORP
LOADING...